Bipolar radiofrequency ablation is useful for treating atrial fibrillation combined with heart valve diseases

BMC Surgery

Renguo Wen¹  Wei Cheng¹  Chuan Qin¹  Jia Hao¹  Baicheng Chen¹  Ruiyan Ma¹  Yingbin Xiao¹  Lin Chen¹ 

[1]Department of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, 7F, Second in-Patient Building, 183 Xinqiao St, Shapingba District, Chongqing 400037, P. R. China

关键词: Atrial fibrillation;    Bipolar;    Radiofrequency ablation;   

Others  :  865766
DOI  :  10.1186/1471-2482-14-32

 received in 2013-02-27, accepted in 2014-05-14,  发布年份 2014

【 摘 要 】

Background

Atrial fibrillation (AF) is a common arrhymia, and it results in increased risk of thromboembolism and decreased cardiac function. In patients undergoing cardiac surgery, concomitant radiofrequency ablation to treat AF is effective in restoring sinus rhythm (SR). This study is an observational cohort study aimed to investigate the safety and efficacy of bipolar radiofrequency ablation (BRFA) for treating AF combined with heart valve diseases.

Methods

Clinical data were analyzed retrospectively from 324 cases of rheumatic heart disease combined with persistent AF patients who underwent valve replacement concomitant BRFA. The modified left atrial and the simplified right atrial ablation were used for AF treatments. Of the 324 patients, 248 patients underwent mitral valve replacement and 76 patients underwent double valve replacement. Meanwhile, 54 patients underwent concomitant thrombectomy and 97 underwent tricuspid valvuloplasty. And all of them received temporary pacemaker implantation. The 24 hours holter electrocardiogram (ECG) monitoring and echocardiography was performed before the operation, on the first day after operation, on discharge day, and at 6 and 12 months after operation.

Results

There were 299 patients with SR on the first day after operation (92.30%), 12 patients with junctional rhythm (3.70%), 11 patients with AF (3.39%), and 2 patients with atrial flutter (0.62%). The temporary pacemaker was used in 213 patients (65.74%) with heart rates less than 70 beat/minute in the ICU. Two patients died early and the mortality rate was 0.62%. Two patients had left ventricular rupture and the occurrence rate was 0.62%. They both recovered. There was no degree III atrioventricular blockage and no permanent pacemaker implantation. Overall survival rate was 99.38% (322 cases) with SR conversion rate of 89.13% (287 cases) at discharge. The SR conversion rate was 87.54% and 87.01% at 6 and 12 months after operation. Sinus bradycardia occurred in 3.42% of patients at 6 months after operation and in 3.03% of patients at 12 months after operation. Echocardiography showed that the left atrial diameter was significantly decreased, and ejection fraction and fractional shortening were significantly improved.

Conclusions

BRFA for treating AF in concomitant valve replacement is safe and with good efficacy.

【 授权许可】

   
2014 Chen et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Sims JB, Roberts WC: Comparison of findings in patients with versus without atrial fibrillation just before isolated mitral valve replacement for rheumatic mitral stenosis (with or without associated mitral regurgitation). Am J Cardiol 2006, 97:1035-1038.
• [2]Hussein AA, Wazni OM, Harb S, Joseph L, Chamsi-Pasha M, Bhargava M, Martin DO, Dresing T, Callahan T, Kanj M, Natale A, Lindsay BD, Saliba WI: Radiofrequency ablation of atrial fibrillation in patients with mechanical mitral valve prostheses. J Am Col Cardiol 2011, 58:596-602.
• [3]Cannom DS: Atrial fibrillation: nonpharmacologic approaches. Am J Cardiol 2000, 85:25D-35D.
• [4]von Oppell UO, Masani N, O'Callaghan P, Wheeler R, Dimitrakakis G, Schiffelers S: Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Euro J Cardio-Thorac Surg 2009, 35:641-650.
• [5]Kim JB, Yun TJ, Chung CH, Choo SJ, Song H, Lee JW: Long-term outcome of modified maze procedure combined with mitral valve surgery: analysis of outcomes according to type of mitral valve surgery. J Thora Cardiovasc Surg 2010, 139:111-117.
• [6]Lakkireddy D, Nagarajan D, Di Biase L, Vanga SR, Mahapatra S, Jared Bunch T, Day JD, Burkhardt DJ, Umbarger L, Dendi R, Pimentel R, Berenbom L, Emert M, Gerken A, Bommana S, Ray W, Atkins D, Murray C, Dawn B, Natale A: Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: A feasibility, safety, and efficacy study. Heart Rhythm 2011, 8:975-980.
• [7]Schulenberg R, Antonitsis P, Stroebel A, Westaby S: Chronic atrial fibrillation is associated with reduced survival after aortic and double valve replacement. Ann Thorac Surg 2010, 89:738-744.
• [8]McCarthy PM, Kruse J, Shalli S, Ilkhanoff L, Goldberger JJ, Kadish AH, Arora R, Lee R: Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J Thorac Cardiovas Surg 2010, 139:860-867.
• [9]Cox JL, Ad N, Palazzo T, Fitzpatrick S, Suyderhoud JP, DeGroot KW, Pirovic EA, Lou HC, Duvall WZ, Kim YD: Current status of the maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovase Surg 2000, 12:15-19.
• [10]Dunninga J, Nagendranb M, Alfieric OR, Eliad S, Kappeteine AP, Lockowandtf U, Sarrisg GE, Kolhh PH: EACTS guideline for the surgical treatment of atrial fibrillation. Eur J Cardiothorac Surg 2013, 44:777-791.
• [11]Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA III, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM: ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 2011(123):104-123.
• [12]Melby SJ, Zierer A, Bailey MS, Cox JL, Lawton JS, Munfakh N, Crabtree TD, Moazami N, Huddleston CB, Moon MR, Damiano RJ Jr: A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg 2006, 244:583-592.
• [13]Srivastava V, Kumar S, Javali S, Rajesh TR, Pai V, Khandekar J, Agrawal N, Patwardhan AM: Efficacy of three different ablative procedures to treat atrial fibrillation in patients with valvular heart disease: a randomised trial. Heart Lung Circ 2008, 17:232-240.
• [14]Basu S, Nagendran M, Maruthappu M: How effective is bipolar radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery? Interact Cardiovasc Thorac Surg 2012, 15:741-748.
• [15]Schuessler RB, Lee AM, Melby SJ, Voeller RK, Gaynor SL, Sakamoto S, Damiano RJ: Animal studies of epicardial atrial ablation. Heart Rhythm 2009, 6(12 Suppl):S41-S45.
• [16]Melby SJ, Zierer A, Voeller RK, Lall SC, Bailey MS, Moon MR, Schuessler RB, Damiano RJ Jr: Wide variations in energy delivery using an impedance-controlled algorithm in bipolar radiofrequency ablation: evidence against fixed time ablation. Innovations 2007, 2:67-72.
• [17]Deniz H, Sokullu O, Sanioglu S, Sargin M, Ozay B, Ayoglu U, Aykut Aka S, Bilgen F: Risk factors for posterior ventricular rupture after mitral valve replacement: results of 2560 patients. Eur J Cardiothorac Surg 2008, 34:780-784.